Tracey D Bradshaw Selected Research

Tracey D Bradshaw Research Topics

Disease

54	Neoplasms (Cancer) 04/2024 - 01/2002
16	Breast Neoplasms (Breast Cancer) 01/2024 - 01/2002
10	Carcinoma (Carcinomatosis) 11/2022 - 02/2002
7	Glioblastoma (Glioblastoma Multiforme) 04/2024 - 01/2010
5	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 10/2011
4	Ovarian Neoplasms (Ovarian Cancer) 03/2021 - 12/2004
3	Glioma (Gliomas) 08/2021 - 01/2010
3	Turcot syndrome 08/2021 - 01/2011
3	Kidney Neoplasms (Kidney Cancer) 05/2020 - 12/2004
3	Brain Neoplasms (Brain Tumor) 03/2020 - 10/2014
2	Aneuploidy (Aneuploid) 08/2021 - 10/2014
2	Lung Neoplasms (Lung Cancer) 03/2020 - 12/2007
2	Adenocarcinoma of Lung 12/2014 - 10/2014
2	Colonic Neoplasms (Colon Cancer) 08/2013 - 01/2005
1	Melanoma (Melanoma, Malignant) 12/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 04/2021
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 07/2020
1	Stomach Neoplasms (Stomach Cancer) 01/2020
1	Carcinogenesis 11/2019
1	Renal Cell Carcinoma (Grawitz Tumor) 12/2017
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2015
1	Nasopharyngeal Carcinoma 10/2014

Drug/Important Bio-Agent (IBA)

11	benzothiazoleIBA 05/2020 - 01/2002
10	Temozolomide (Temodar)FDA LinkGeneric 04/2024 - 01/2010
7	ApoferritinsIBA 01/2024 - 12/2013
6	Proteins (Proteins, Gene)FDA Link 04/2024 - 02/2002
6	Antineoplastic Agents (Antineoplastics)IBA 05/2020 - 01/2002
6	2- (4- amino- 3- methylphenyl)- 5- fluorobenzothiazoleIBA 01/2020 - 02/2002
6	2- (3,4- dimethoxyphenyl)- 5- fluorobenzothiazoleIBA 01/2019 - 01/2006
5	ProdrugsIBA 04/2024 - 02/2002
5	Transferrin Receptors (Transferrin Receptor)IBA 01/2024 - 01/2019
5	HydroquinonesIBA 05/2010 - 01/2005
4	jerantinine AIBA 01/2024 - 10/2014
4	PhortressIBA 05/2020 - 09/2004
4	BenzothiazolesIBA 05/2020 - 02/2003
4	DNA AdductsIBA 01/2019 - 09/2004
4	MethyltransferasesIBA 03/2018 - 01/2011
4	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 10/2013 - 09/2004
3	LigandsIBA 12/2022 - 12/2017
3	CaspasesIBA 11/2022 - 01/2015
3	AlkaloidsIBA 06/2022 - 10/2014
3	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 05/2020 - 01/2002
3	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 12/2004
3	NSC 674495IBA 07/2008 - 01/2002
2	Cisplatin (Platino)FDA LinkGeneric 02/2024 - 11/2022
2	ThiazolesIBA 09/2023 - 11/2022
2	Acetates (Acetic Acid Esters)FDA Link 06/2022 - 01/2016
2	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2021 - 10/2009
2	Alkylating AgentsIBA 08/2021 - 01/2010
2	aminoflavoneIBA 05/2020 - 12/2017
2	O-(6)-methylguanineIBA 03/2020 - 01/2010
2	TitaniumIBA 02/2017 - 03/2016
2	TubulinIBA 01/2017 - 10/2014
2	titanoceneIBA 03/2016 - 02/2016
2	TocotrienolsIBA 12/2014 - 10/2014
2	3- (5- fluoro- 4- (4- methyl- 2- (methylamino)thiazol- 5- yl)pyrimidin- 2- ylamino)benzenesulfonamideIBA 09/2014 - 01/2014
2	RNA (Ribonucleic Acid)IBA 09/2014 - 01/2014
2	Thioredoxin-Disulfide ReductaseIBA 01/2010 - 05/2005
2	ThioredoxinsIBA 10/2006 - 05/2005
2	Messenger RNA (mRNA)IBA 12/2004 - 09/2004
2	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 09/2004 - 02/2002
1	TriazolesIBA 12/2022
1	CytokinesIBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	benzylamineIBA 08/2021
1	thymoquinoneIBA 08/2021
1	dipinacoline glutamateIBA 08/2021
1	cardamoninIBA 04/2021
1	Apoptosis Regulatory ProteinsIBA 03/2021
1	pyrimidineIBA 03/2021
1	jerantinine BIBA 07/2020
1	Angiogenesis InhibitorsIBA 05/2020
1	Sunitinib (Sutent)FDA Link 05/2020
1	ceritinibIBA 03/2020
1	2- (1H- indazol- 4- yl)- 6- (4- methanesulfonylpiperazin- 1- ylmethyl)- 4- morpholin- 4- ylthieno(3,2- d)pyrimidineIBA 03/2020
1	Cysteine Proteinase InhibitorsIBA 11/2019
1	Cysteine Proteases (Cysteine Protease)IBA 11/2019
1	Cathepsin LIBA 11/2019
1	NanogelsIBA 06/2019
1	Caspase 3 (Caspase-3)IBA 01/2019
1	cerberinIBA 01/2019
1	CardenolidesIBA 01/2019
1	CarbamatesIBA 01/2018
1	imidazoleIBA 01/2018
1	DNA Repair EnzymesIBA 01/2018
1	AmidesIBA 01/2018
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2017
1	RNA Splicing FactorsIBA 01/2017
1	Nucleosomes (Nucleosome)IBA 01/2017
1	cudraflavone CIBA 01/2017
1	Indole AlkaloidsIBA 01/2017
1	Small Interfering RNA (siRNA)IBA 01/2017
1	piperlongumineIBA 08/2016
1	Gefitinib (Iressa)FDA Link 12/2015
1	ON 01910IBA 01/2015
1	delta tocotrienolIBA 12/2014

Therapy/Procedure

9	Therapeutics 04/2024 - 02/2003
3	Drug Therapy (Chemotherapy) 12/2018 - 01/2015
2	Aftercare (After-Treatment) 10/2014 - 02/2002